Building a Renal Denervation Program-Introduction

Video Transcription

Video Summary

In this video, Ty Cobayashi and Erickson Samstian, interventionalists at Huntsville University and Beth Isgrove respectively, thank industry partners Petronic and ReCore for attending a satellite session on renal generation. The panel discussion, one of the first on the role of renal denervation in hypertension treatment, focuses on building a program to prepare for the device's availability post-FDA approval. The session features high-level experts, including Michael Bloch and Debbie Cohen, who share their experiences and discuss the state of the therapy. They hope that this will be the last time discussing it without it being clinically available.

Asset Subtitle

Tai Kobayashi, MD, FSCAI

Keywords

renal denervation

hypertension treatment

FDA approval

high-level experts

clinical availability